Shelton Capital Management Takeda Pharmaceutical CO LTD Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$16.55 - $18.64 $166,625 - $187,667	-10,068 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$13.02 - $20.31 $846 - $1,320	-65 Reduced 0.64%	10,068 $153,000
Q4 2019 Feb 11, 2020	SELL	$16.88 - $20.83 $600,928 - $741,547	-35,600 Reduced 77.84%	10,133 $200,000
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $742,800 - $917,972	44,801 Added 4806.97%	45,733 $809,000
Q1 2019 May 10, 2019	BUY	$16.7 - $21.52 $15,564 - $20,056	932 New	932 $45.7 Million

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.